BioCentury
ARTICLE | Clinical News

Angeliq oral once-daily estradiol and drospirenone low dose hormone replacement therapy regulatory update

July 14, 2003 7:00 AM UTC

SCH said the EU concluded the Mutual Recognition approval procedure for Angeliq and that the company will launch the product this fall. The reference state, the Netherlands, approved Angeliq last year...